Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can talking therapy keep young psychosis patients in treatment?

NCT ID NCT05310838

Knowledge-focused Sponsor: California State University, San Bernardino Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 2 times

Summary

This study compares a 12-session behavioral activation program to usual care for 58 Latino individuals aged 15–35 with first-episode psychosis. The goal is to see if the program improves how actively patients engage in their own care. Researchers will measure engagement and quality of life over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Behavioral activation therapy
What this could lead to
If successful, this could point toward a simple, talk-based way to help people with early psychosis stay engaged in their care.
What could go wrong
This is a small, early-stage study with only 58 participants, so results may not apply to everyone. The intervention is behavioral, not a drug, so effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

28 people

The number who actually took part.

Started

Mar 2022

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 35 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-identification as Latino * Age 15 to 35 * Diagnostic \& Statistical Manual of Mental Disorders-5 diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, other specified schizophrenia spectrum, affective psychosis, and other psychotic disorder criteria * Ability to speak English or Spanish * Caregiver willing to consent to participate in the study and care * Ability to provide fully informed consent Exclusion Criteria: * Diagnosis of psychotic disorder due to another medical condition or substance/medication-induced psychotic disorder * Presence of a serious medical condition * 3≤ years after the onset

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Engagement, patient are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Engagement, patient First episode psychosis

Contacts and locations

Locations

  • Olive View - UCLA Medical Center

    Sylmar, California, 91342, United States

  • San Fernando Mental Health Center

    Granada Hills, California, 91344, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.